Treanor Charlene J, Santin Olinda, Prue Gillian, Coleman Helen, Cardwell Chris R, O'Halloran Peter, Donnelly Michael
Centre for Public Health, Queen's University Belfast, Institute of Clinical Sciences Block B, Royal Victoria Hospital Site, Grosvenor Road, Belfast, Northern Ireland, UK, BT12 6BJ.
Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD009912. doi: 10.1002/14651858.CD009912.pub2.
Increasingly, cancer is recognised as a chronic condition with a growing population of informal caregivers providing care for cancer patients. Informal caregiving can negatively affect the health and well-being of caregivers. We need a synthesised account of best evidence to aid decision-making about effective ways to support caregivers for individuals 'living with cancer'.
To assess the effectiveness of psychosocial interventions designed to improve the quality of life (QoL), physical health and well-being of informal caregivers of people living with cancer compared with usual care.
We searched CENTRAL, MEDLINE, Embase, PsycINFO, ProQuest, Open SIGLE, Web of Science from inception up to January 2018, trial registries and citation lists of included studies.
We included randomised and quasi-randomised controlled trials comparing psychosocial interventions delivered to adult informal caregivers of adults affected by cancer on a group or individual basis with usual care. Psychosocial interventions included non-pharmacological interventions that involved an interpersonal relationship between caregivers and healthcare professionals. We included interventions delivered also to caregiver-patient dyads. Interventions delivered to caregivers of individuals receiving palliative or inpatient care were excluded. Our primary outcome was caregiver QoL. Secondary outcomes included patient QoL, caregiver and patient depression, anxiety, psychological distress, physical health status and intervention satisfaction and adverse effects.
Pairs of review authors independently screened studies for eligibility, extracted data and conducted 'Risk of bias' assessments. We synthesised findings using meta-analysis, where possible, and reported remaining results in a narrative synthesis.
Nineteen trials (n = 3, 725) were included in the review. All trials were reported in English and were undertaken in high-income countries. Trials targeted caregivers of patients affected by a number of cancers spanning newly diagnosed patients, patients awaiting treatment, patients who were being treated currently and individuals post-treatment. Most trials delivered interventions to caregiver-patient dyads (predominantly spousal dyads) and there was variation in intervention delivery to groups or individual participants. There was much heterogeneity across interventions though the majority were defined as psycho-educational. All trials were rated as being at 'high risk of bias'.Compared to usual care, psychosocial interventions may improve slightly caregiver QoL immediately post intervention (standardised mean difference (SMD) 0.29, 95% confidence interval (CI) 0.04 to 0.53; studies = 2, 265 participants) and may have little to no effect on caregiver QoL at 12 months (SMD 0.14, 95% CI - 0.11 to 0.40; studies = 2, 239 participants) post-intervention (both low-quality evidence).Psychosocial interventions probably have little to no effect on caregiver depression immediately to one-month post-intervention (SMD 0.01, 95% CI -0.14 to 0.15; studies = 9, 702 participants) (moderate-quality evidence). Psychosocial interventions may have little to no effect on caregiver anxiety immediately post-intervention (SMD -0.12, 95 % CI -0.33 to 0.10; studies = 5, 329 participants), depression three-to-six months (SMD 0.03, 95% CI -0.33 to 0.38; studies = 5. 379 participants) post-intervention and patient QoL six to 12 months (SMD -0.05, 95% CI -0.37 to 0.26; studies = 3, 294 participants) post-intervention (all low-quality evidence). There was uncertainty whether psychosocial interventions improve patient QoL immediately (SMD -0.03, 95 %CI -0.50 to 0.44; studies = 2, 292 participants) or caregiver anxiety three-to-six months (SMD-0.25, 95% CI -0.64 to 0.13; studies = 4, 272 participants) post-intervention (both very low-quality evidence). Two studies which could not be pooled in a meta-analysis for caregiver physical health status found little to no effect immediately post-intervention and a small intervention effect 12 months post-intervention. Caregiver or patient satisfaction or cost-effectiveness of interventions were not assessed in any studies. Interventions demonstrated good feasibility and acceptability.Psychosocial interventions probably have little to no effect on patient physical health status immediately post-intervention (SMD 0.17, 95 % CI -0.07 to 0.41; studies = 4, 461 participants) and patient depression three to six months post-intervention (SMD-0.11, 95% CI -0.33 to 0.12; studies = 6, 534 participants) (both moderate-quality evidence).Psychosocial interventions may have little to no effect on caregiver psychological distress immediately to one-month (SMD -0.08, 95% CI -0.42 to 0.26; studies = 3, 134 participants), and seven to 12 months (SMD 0.08, 95% CI -0.42 to 0.58; studies = 2, 62 participants) post-intervention; patient depression immediately (SMD -0.12, 95% CI -0.31 to 0.07; studies = 9, 852 participants); anxiety immediately (SMD -0.13, 95% CI -0.41 to 0.15;studies = 4, 422 participants), and three to six months (SMD -0.22, 95% CI -0.45 to 0.02; studies = 4, 370 participants); psychological distress immediately (SMD -0.02, 95% CI -0.47 to 0.44; studies = 2, 74 participants) and seven to 12 months (SMD -0.27, 95% CI -0.78 to 0.24; studies = 2, 61 participants); and physical health status six to 12 months (SMD 0.06, 95% CI -0.18 to 0.30; studies = 2, 275 participants) post-intervention (all low-quality evidence).Three trials reported adverse effects associated with the interventions, compared with usual care, including higher distress, sexual function-related distress and lower relationship satisfaction levels for caregivers, higher distress levels for patients, and that some content was perceived as insensitive to some participants.Trials not able to be pooled in a meta-analysis did not tend to report effect size and it was difficult to discern intervention effectiveness. Variable intervention effects were reported for patient and caregiver outcomes.
AUTHORS' CONCLUSIONS: Heterogeneity across studies makes it difficult to draw firm conclusions regarding the effectiveness of psychosocial interventions for this population. There is an immediate need for rigorous trials with process evaluations and clearer, detailed intervention descriptions. Cost-effectiveness studies should be conducted alongside future trials.
癌症越来越被视为一种慢性病,为癌症患者提供护理的非正式照护者群体不断壮大。非正式照护可能会对照护者的健康和幸福产生负面影响。我们需要一份综合的最佳证据报告,以帮助就支持“癌症患者”照护者的有效方式做出决策。
评估与常规护理相比,旨在改善癌症患者非正式照护者生活质量(QoL)、身体健康和幸福感的心理社会干预措施的有效性。
我们检索了Cochrane系统评价数据库(CENTRAL)、医学期刊数据库(MEDLINE)、荷兰医学文摘数据库(Embase)、心理学文摘数据库(PsycINFO)、ProQuest数据库、Open SIGLE数据库、科学引文索引(Web of Science),检索时间从各数据库建库至2018年1月,还检索了试验注册库以及纳入研究的参考文献列表。
我们纳入了随机对照试验和半随机对照试验,这些试验比较了针对成年癌症患者的成年非正式照护者的心理社会干预措施(以小组或个体形式提供)与常规护理。心理社会干预措施包括涉及照护者与医疗保健专业人员之间人际关系的非药物干预措施。我们纳入了也针对照护者-患者二元组的干预措施。排除针对接受姑息治疗或住院治疗患者的照护者的干预措施。我们的主要结局是照护者的生活质量。次要结局包括患者的生活质量、照护者和患者的抑郁、焦虑、心理困扰、身体健康状况以及干预满意度和不良反应。
由两位综述作者独立筛选研究以确定其是否符合纳入标准、提取数据并进行“偏倚风险”评估。我们尽可能使用Meta分析来综合研究结果,并以叙述性综述的形式报告其余结果。
本综述纳入了19项试验(n = 3725)。所有试验均以英文发表,且均在高收入国家进行。试验针对受多种癌症影响患者的照护者,涵盖新诊断患者、等待治疗的患者、正在接受治疗的患者以及治疗后的患者。大多数试验将干预措施提供给照护者-患者二元组(主要是配偶二元组),并且在向小组或个体参与者提供干预措施方面存在差异。尽管大多数干预措施被定义为心理教育,但各干预措施之间存在很大异质性。所有试验均被评为“高偏倚风险”。与常规护理相比,心理社会干预措施可能在干预后立即略微改善照护者的生活质量(标准化均数差(SMD)0.29,95%置信区间(CI)0.04至0.53;研究 = 2,265名参与者),而在干预后12个月对照护者的生活质量可能几乎没有影响(SMD 0.14,95%CI -0.11至0.40;研究 = 2,239名参与者)(均为低质量证据)。心理社会干预措施可能在干预后立即至干预后1个月对照护者的抑郁几乎没有影响(SMD 0.01,95%CI -0.14至0.15;研究 = 9,702名参与者)(中等质量证据)。心理社会干预措施可能在干预后立即对照护者的焦虑几乎没有影响(SMD -0.12,95%CI -0.33至0.10;研究 = 5,329名参与者),在干预后3至6个月对照护者的抑郁几乎没有影响(SMD 0.03,95%CI -0.33至0.38;研究 = 5,379名参与者),在干预后6至12个月对患者的生活质量几乎没有影响(SMD -0.05,95%CI -0.37至0.26;研究 = 3,294名参与者)(均为低质量证据)。心理社会干预措施在干预后立即是否能改善患者的生活质量(SMD -0.03,95%CI -0.50至0.44;研究 = 2,292名参与者)或在干预后3至6个月是否能改善照护者的焦虑(SMD -0.25,95%CI -0.64至0.13;研究 = 4,272名参与者)尚不确定(均为极低质量证据)。两项无法纳入照护者身体健康状况Meta分析的研究发现,干预后立即几乎没有影响,干预后12个月有较小的干预效果。在任何研究中均未评估干预措施的照护者或患者满意度或成本效益。干预措施显示出良好的可行性和可接受性。心理社会干预措施可能在干预后立即对患者的身体健康状况几乎没有影响(SMD 0.17,95%CI -0.07至0.41;研究 = 4,461名参与者),在干预后3至6个月对患者的抑郁几乎没有影响(SMD -0.11,95%CI -0.33至0.12;研究 = 6,534名参与者)(均为中等质量证据)。心理社会干预措施可能在干预后立即至1个月对照护者的心理困扰几乎没有影响(SMD -0.08,95%CI -0.42至0.26;研究 = 3,134名参与者),在干预后7至12个月对照护者的心理困扰几乎没有影响(SMD 0.08,95%CI -0.42至0.58;研究 = 2,62名参与者);对患者的抑郁在干预后立即几乎没有影响(SMD -0.12,95%CI -0.31至0.07;研究 = 9,852名参与者);对患者的焦虑在干预后立即几乎没有影响(SMD -0.13,95%CI -0.41至0.15;研究 = 4,422名参与者),在干预后3至6个月几乎没有影响(SMD -0.22,95%CI -0.45至0.02;研究 = 4,370名参与者);对患者的心理困扰在干预后立即几乎没有影响(SMD -0.02,95%CI -0.47至0.44;研究 = 2,74名参与者),在干预后7至12个月几乎没有影响(SMD -0.27,95%CI -0.78至0.24;研究 = 2,61名参与者);在干预后6至12个月对患者的身体健康状况几乎没有影响(SMD 0.06,95%CI -0.18至0.30;研究 = 2,275名参与者)(均为低质量证据)。三项试验报告了与干预措施相关的不良反应,与常规护理相比,包括照护者更高的困扰、性功能相关困扰和更低的关系满意度水平,患者更高的困扰水平,以及一些内容被一些参与者认为不敏感。无法纳入Meta分析的试验往往未报告效应量,难以辨别干预效果。对于患者和照护者的结局报告了不同的干预效果。
研究之间的异质性使得难以就心理社会干预措施对该人群的有效性得出确凿结论。迫切需要进行严格的试验,并进行过程评估以及更清晰、详细的干预描述。成本效益研究应与未来的试验同时进行。